Cardiac-specific overexpression of GTP cyclohydrolase 1 restores ischaemic preconditioning during hyperglycaemia
Authors:
Open Access
- 21 March 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 91 (2) , 340-349
Abstract
Hyperglycaemia (HG) decreases intracellular tetrahydrobiopterin (BH4) concentrations, and this action may contribute to injury during myocardial ischaemia and reperfusion. We investigated whether increased BH4 by cardiomyocyte-specific overexpression of the GTP cyclohydrolase (GTPCH) 1 gene rescues myocardial and mitochondrial protection by ischaemic preconditioning (IPC) during HG through a nitric oxide (NO)-dependent pathway. Mice underwent 30 min of myocardial ischaemia followed by 2 h of reperfusion with or without IPC elicited with four cycles of 5 min ischaemia/5 min of reperfusion in the presence or absence of HG produced by d-glucose. In C57BL/6 wild-type mice, IPC increased myocardial BH4 and NO concentrations and decreased myocardial infarct size (30 ± 3% of risk area) compared with control (56 ± 5%) experiments. This protective effect was inhibited by HG (48 ± 3%) but not hyperosmolarity. GTPCH-1 overexpression increased myocardial BH4 and NO concentrations and restored cardioprotection by IPC during HG (32 ± 4%). In contrast, a non-selective NO synthase inhibitor NG-nitro-l-arginine methyl ester attenuated the favourable effects of GTPCH-1 overexpression (52 ± 3%) during HG. Mitochondria isolated from myocardium subjected to IPC required significantly higher in vitro Ca2+ concentrations (184 ± 14 µmol mg−1 protein) to open the mitochondrial permeability transition pore when compared with mitochondria isolated from control experiments (142 ± 10 µmol mg−1 protein). This beneficial effect of IPC was reversed by HG and rescued by GTPCH-1 overexpression. Increased BH4 by cardiomyocyte-specific overexpression of GTPCH-1 preserves the ability of IPC to elicit myocardial and mitochondrial protection that is impaired by HG, and this action appears to be dependent on NO.Keywords
This publication has 50 references indexed in Scilit:
- A3 adenosine receptor activation during reperfusion reduces infarct size through actions on bone marrow-derived cellsJournal of Molecular and Cellular Cardiology, 2010
- Cardiac myocyte-specific overexpression of human GTP cyclohydrolase I protects against acute cardiac allograft rejectionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Hyperglycemia Adversely Modulates Endothelial Nitric Oxide Synthase during Anesthetic Preconditioning through Tetrahydrobiopterin– and Heat Shock Protein 90–mediated MechanismsAnesthesiology, 2010
- Sepiapterin Decreases Acute Rejection and Apoptosis in Cardiac Transplants Independently of Changes in Nitric Oxide and Inducible Nitric-Oxide Synthase DimerizationThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Role of Heat Shock Protein 90 and Endothelial Nitric Oxide Synthase during Early Anesthetic and Ischemic PreconditioningAnesthesiology, 2009
- Deficient BH4production via de novo and salvage pathways regulates NO responses to cytokines in adult cardiac myocytesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen speciesCardiovascular Research, 2008
- Endothelial nitric oxide synthase is not necessary for the early phase of ischemic preconditioning in the mouseJournal of Molecular and Cellular Cardiology, 2008
- Myocardial ischemia results in tetrahydrobiopterin (BH 4 ) oxidation with impaired endothelial function ameliorated by BH 4Proceedings of the National Academy of Sciences, 2007
- Cl-IB-MECA [2-Chloro-N6-(3-iodobenzyl)adenosine-5′-N-methylcarboxamide] Reduces Ischemia/Reperfusion Injury in Mice by Activating the A Adenosine ReceptorThe Journal of Pharmacology and Experimental Therapeutics, 2006